title: Iris neovascularization after vitrectomy combined with phacoemulsification and intraocular lens implantation for proliferative diabetic retinopathy.
abstract: OBJECTIVE
  To analyze the incidence of iris neovascularization after vitrectomy combined with phacoemulsification and intraocular lens (IOL) implantation using a small incision in the treatment of proliferative diabetic retinopathy (PDR).
  
  
  METHODS
  We studied a consecutive series of 46 eyes in which vitrectomy combined with phacoemulsification and IOL implantation had been performed, and compared the surgical results with a prior series of 40 eyes in which vitrectomy alone had been performed.
  
  
  RESULTS
  Postoperative iris and angle neovascularization was found in 6 eyes (15%) treated by vitrectomy alone, but in only 1 eye (2%) treated by combined vitrectomy (P<0.05). Final visual acuity improved by two or more lines in 23 eyes (57%) in the vitrectomy alone group, and in 35 eyes (76%) in the combined vitrectomy group.
  
  
  CONCLUSIONS
  The incidence of postoperative rubeosis iridis was significantly lower, and the visual results were satisfactory with vitrectomy combined with phacoemulsification and IOL implantation for PDR. These findings suggest that combined vitrectomy for PDR is a useful surgical procedure.
authors.affiliation: Department of Ophthalmology, Yokohama City University Medical Center, Japan. kado@med.yokohama-cu.ac.jp
authors.forename: K
authors.initials: K
authors.lastname: Kadonosono
authors.forename: S
authors.initials: S
authors.lastname: Matsumoto
authors.forename: E
authors.initials: E
authors.lastname: Uchio
authors.forename: M
authors.initials: M
authors.lastname: Sugita
authors.forename: J
authors.initials: J
authors.lastname: Akura
authors.forename: S
authors.initials: S
authors.lastname: Ohno
mesh_terms: D000328:Adult; D000368:Aged; D003930:Diabetic Retinopathy / Q000601:surgery*; D005260:Female; D006801:Humans; D015994:Incidence; D007498:Iris / Q000098:blood supply*; D019654:Lens Implantation, Intraocular / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D009389:Neovascularization, Pathologic / Q000209:etiology*; D018918:Phacoemulsification / Q000009:adverse effects*; D012189:Retrospective Studies; D014792:Visual Acuity; D014821:Vitrectomy / Q000009:adverse effects*